112 related articles for article (PubMed ID: 37559472)
1. Targeting HSP90 with picropodophyllin suppresses gastric cancer tumorigenesis by disrupting the association of HSP90 and AKT.
Li X; Wang G; Zhou X; Zhao H; Chen X; Cui Q; Li M; Gao X; Wei X; Ye L; Li D; Hong P
Phytother Res; 2023 Oct; 37(10):4740-4754. PubMed ID: 37559472
[TBL] [Abstract][Full Text] [Related]
2. Picropodophyllin Inhibits the Proliferation of Human Prostate Cancer DU145 and LNCaP Cells via ROS Production and PI3K/AKT Pathway Inhibition.
Zhu X; Chen X; Wang G; Lei D; Chen X; Lin K; Li M; Lin H; Li D; Zheng Q
Biol Pharm Bull; 2022; 45(8):1027-1035. PubMed ID: 35908886
[TBL] [Abstract][Full Text] [Related]
3. Picropodophyllin inhibits the growth of Ewing's sarcoma cells through the insulin‑like growth factor‑1 receptor/Akt signaling pathway.
Wu YT; Wang BJ; Miao SW; Gao JJ
Mol Med Rep; 2015 Nov; 12(5):7045-50. PubMed ID: 26323364
[TBL] [Abstract][Full Text] [Related]
4. Picropodophyllin inhibits proliferation and survival of diffuse large B-cell lymphoma cells.
Strömberg T; Feng X; Delforoush M; Berglund M; Lin Y; Axelson M; Larsson O; Georgii-Hemming P; Lennartsson J; Enblad G
Med Oncol; 2015 Jul; 32(7):188. PubMed ID: 26021470
[TBL] [Abstract][Full Text] [Related]
5. Targeting the insulin-like growth factor-1 receptor by picropodophyllin for lung cancer chemoprevention.
Zhang Q; Pan J; Lubet RA; Wang Y; You M
Mol Carcinog; 2015 Jun; 54 Suppl 1():E129-37. PubMed ID: 25163779
[TBL] [Abstract][Full Text] [Related]
6. HER2/ErbB2 activates HSF1 and thereby controls HSP90 clients including MIF in HER2-overexpressing breast cancer.
Schulz R; Streller F; Scheel AH; Rüschoff J; Reinert MC; Dobbelstein M; Marchenko ND; Moll UM
Cell Death Dis; 2014 Jan; 5(1):e980. PubMed ID: 24384723
[TBL] [Abstract][Full Text] [Related]
7. FW-04-806 inhibits proliferation and induces apoptosis in human breast cancer cells by binding to N-terminus of Hsp90 and disrupting Hsp90-Cdc37 complex formation.
Huang W; Ye M; Zhang LR; Wu QD; Zhang M; Xu JH; Zheng W
Mol Cancer; 2014 Jun; 13():150. PubMed ID: 24927996
[TBL] [Abstract][Full Text] [Related]
8. Targeting heat-shock protein 90 improves efficacy of rapamycin in a model of hepatocellular carcinoma in mice.
Lang SA; Moser C; Fichnter-Feigl S; Schachtschneider P; Hellerbrand C; Schmitz V; Schlitt HJ; Geissler EK; Stoeltzing O
Hepatology; 2009 Feb; 49(2):523-32. PubMed ID: 19085954
[TBL] [Abstract][Full Text] [Related]
9. Huachansu Capsule inhibits the proliferation of human gastric cancer cells via Akt/mTOR pathway.
Ni T; Wang H; Li D; Tao L; Lv M; Jin F; Wang W; Feng J; Qian Y; Sunagawa M; Liu Y
Biomed Pharmacother; 2019 Oct; 118():109241. PubMed ID: 31351435
[TBL] [Abstract][Full Text] [Related]
10. Exosomal circSHKBP1 promotes gastric cancer progression via regulating the miR-582-3p/HUR/VEGF axis and suppressing HSP90 degradation.
Xie M; Yu T; Jing X; Ma L; Fan Y; Yang F; Ma P; Jiang H; Wu X; Shu Y; Xu T
Mol Cancer; 2020 Jun; 19(1):112. PubMed ID: 32600329
[TBL] [Abstract][Full Text] [Related]
11. Vernodalin Suppresses Tumor Proliferation and Increases Apoptosis of Gastric Cancer Cells Through Attenuation of FAK/PI3K/AKT/mTOR and MAPKs Signaling Pathways.
Luo Y; Zhang D; Hou L; Lin N
Curr Pharm Biotechnol; 2023; 24(5):708-717. PubMed ID: 35909270
[TBL] [Abstract][Full Text] [Related]
12. Metformin suppresses growth and adrenocorticotrophic hormone secretion in mouse pituitary corticotroph tumor AtT20 cells.
Jin K; Ruan L; Pu J; Zhong A; Wang F; Tan S; Huang H; Mu J; Yang G
Mol Cell Endocrinol; 2018 Dec; 478():53-61. PubMed ID: 30025915
[TBL] [Abstract][Full Text] [Related]
13. The GAS5/miR-222 Axis Regulates Proliferation of Gastric Cancer Cells Through the PTEN/Akt/mTOR Pathway.
Li Y; Gu J; Lu H
Dig Dis Sci; 2017 Dec; 62(12):3426-3437. PubMed ID: 29098549
[TBL] [Abstract][Full Text] [Related]
14. The association of TP53 mutations with the resistance of colorectal carcinoma to the insulin-like growth factor-1 receptor inhibitor picropodophyllin.
Wang Q; Wei F; Lv G; Li C; Liu T; Hadjipanayis CG; Zhang G; Hao C; Bellail AC
BMC Cancer; 2013 Nov; 13():521. PubMed ID: 24182354
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of novel dual inhibitors of heat shock protein 90/mammalian target of rapamycin (Hsp90/mTOR) against bladder cancer cells.
Pan Z; Chen Y; Pang H; Wang X; Zhang Y; Xie X; He G
Eur J Med Chem; 2022 Nov; 242():114674. PubMed ID: 35987020
[TBL] [Abstract][Full Text] [Related]
16. Bruceantin targets HSP90 to overcome resistance to hormone therapy in castration-resistant prostate cancer.
Moon SJ; Jeong BC; Kim HJ; Lim JE; Kim HJ; Kwon GY; Jackman JA; Kim JH
Theranostics; 2021; 11(2):958-973. PubMed ID: 33391515
[No Abstract] [Full Text] [Related]
17. HSP70/HSP90-Organizing Protein Contributes to Gastric Cancer Progression in an Autocrine Fashion and Predicts Poor Survival in Gastric Cancer.
Zhai E; Liang W; Lin Y; Huang L; He X; Cai S; Chen J; Zhang N; Li J; Zhang Q; He Y; Zeng Z; Chen M; Xu L; Peng S
Cell Physiol Biochem; 2018; 47(2):879-892. PubMed ID: 29843139
[TBL] [Abstract][Full Text] [Related]
18. Blocking NF-κB and Akt by Hsp90 inhibition sensitizes Smac mimetic compound 3-induced extrinsic apoptosis pathway and results in synergistic cancer cell death.
Bai L; Xu S; Chen W; Li Z; Wang X; Tang H; Lin Y
Apoptosis; 2011 Jan; 16(1):45-54. PubMed ID: 20862547
[TBL] [Abstract][Full Text] [Related]
19. Targeting heat-shock protein 90 with ganetespib for molecularly targeted therapy of gastric cancer.
Liu H; Lu J; Hua Y; Zhang P; Liang Z; Ruan L; Lian C; Shi H; Chen K; Tu Z
Cell Death Dis; 2015 Jan; 6(1):e1595. PubMed ID: 25590805
[TBL] [Abstract][Full Text] [Related]
20. MCM6 is a critical transcriptional target of YAP to promote gastric tumorigenesis and serves as a therapeutic target.
Wang Y; Chen H; Liu W; Yan H; Zhang Y; Cheung AHK; Zhang J; Chen B; Liang L; Zhou Z; Wong CC; Wu WKK; Chan MWY; Cheng ASL; Ma BBY; Yu J; Lo KW; To KF; Kang W
Theranostics; 2022; 12(15):6509-6526. PubMed ID: 36185598
[No Abstract] [Full Text] [Related]
[Next] [New Search]
